Your browser doesn't support javascript.
loading
Peptide-based targeted cancer therapeutics: Design, synthesis and biological evaluation.
Iwanov, Iwan; Rossi, Arianna; Montesi, Monica; Doytchinova, Irini; Sargsyan, Armen; Momekov, Georgi; Panseri, Silvia; Naydenova, Emilia.
  • Iwanov I; University of Chemical Technology and Metallurgy, 8 Blvd. Kliment Ohridski, Sofia 1756, Bulgaria.
  • Rossi A; Institute of Science and Technology for Ceramics, National Research Council of Italy, via Granarolo 64, Faenza (RA), Italy; University of Messina, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, Piazza Pugliatti 1, Messina (ME), Italy.
  • Montesi M; Institute of Science and Technology for Ceramics, National Research Council of Italy, via Granarolo 64, Faenza (RA), Italy.
  • Doytchinova I; Medical University of Sofia, 2 Dunav st., Sofia 1000, Bulgaria. Electronic address: idoytchinova@pharmfac.mu-sofia.bg.
  • Sargsyan A; Scientific and Production Center "Armbiotechnology" NAS RA, 14 Gyurjyan str., Yerevan 0056, Armenia.
  • Momekov G; Medical University of Sofia, 2 Dunav st., Sofia 1000, Bulgaria.
  • Panseri S; Institute of Science and Technology for Ceramics, National Research Council of Italy, via Granarolo 64, Faenza (RA), Italy. Electronic address: silvia.panseri@istec.cnr.it.
  • Naydenova E; University of Chemical Technology and Metallurgy, 8 Blvd. Kliment Ohridski, Sofia 1756, Bulgaria. Electronic address: emilia@uctm.edu.
Eur J Pharm Sci ; 176: 106249, 2022 Sep 01.
Article en En | MEDLINE | ID: mdl-35779821

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Glioblastoma / Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Glioblastoma / Antineoplásicos Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article